| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11920-003-0003-7 |
| P698 | PubMed publication ID | 12685996 |
| P50 | author | Eric Hollander | Q107871887 |
| P2093 | author name string | Stefano Pallanti | |
| Erica D Sood | |||
| P2860 | cites work | Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder | Q32114341 |
| Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness | Q33880704 | ||
| Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling | Q33948583 | ||
| A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling | Q34135868 | ||
| Pathological gambling. A psychobiological study | Q34403473 | ||
| Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators | Q34404992 | ||
| Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a double-blind comparison | Q71216972 | ||
| Affective disorders among pathological gamblers seeking treatment | Q71254283 | ||
| Enzymes related to biogenic amine metabolism and personality characteristics in depressed patients | Q71285898 | ||
| Behavioral effects of naloxone infusion in obsessive-compulsive disorder | Q71501753 | ||
| Compulsive exhibitionism successfully treated with fluvoxamine: a controlled case study | Q72152257 | ||
| Obsessive compulsive spectrum disorders | Q72152261 | ||
| Access to gambling opportunities and compulsive gambling | Q72463578 | ||
| Exhibitionism treated with clomipramine | Q72824752 | ||
| Multicentre, double-blind, comparison of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder | Q73663259 | ||
| A randomized double-blind fluvoxamine/placebo crossover trial in pathologic gambling | Q73794738 | ||
| Naltrexone in the treatment of pathological gambling and alcohol dependence | Q74290952 | ||
| The treatment of kleptomania with serotonin reuptake inhibitors | Q74521671 | ||
| Short-term single-blind fluvoxamine treatment of pathological gambling | Q77646710 | ||
| SSRI-induced mania in obsessive-compulsive disorder | Q77808496 | ||
| Association of polymorphisms of dopamine D2 receptor (DRD2), and dopamine transporter (DAT1) genes with schizoid/avoidant behaviors (SAB). | Q34426331 | ||
| Efficacy and safety of fluvoxamine in body dysmorphic disorder. | Q34468409 | ||
| A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling) | Q34540004 | ||
| Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons | Q36317322 | ||
| Pharmacological adjuncts in the treatment of opioid and cocaine addicts | Q39568049 | ||
| An open-label study of citalopram in the treatment of pathological gambling | Q40661279 | ||
| Suicide attempts, platelet monoamine oxidase and the average evoked response | Q40806534 | ||
| Estimating the prevalence of adolescent gambling disorders: A quantitative synthesis and guide toward standard gambling nomenclature | Q40936593 | ||
| Diagnosis, neurobiology, and treatment of pathological gambling. | Q41027250 | ||
| Cerebrospinal fluid monoamine metabolite levels in male arsonists | Q41248902 | ||
| Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo | Q41259841 | ||
| A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder. | Q43577338 | ||
| A comparison of citalopram and paroxetine in the treatment of panic disorder: a randomized, single-blind study. | Q43659483 | ||
| Citalopram for social phobia: a clinical case series | Q43712927 | ||
| A pilot placebo-controlled study of fluvoxamine for pathological gambling. | Q44015745 | ||
| Lithium and valproate treatment of pathological gambling: a randomized single-blind study. | Q44080281 | ||
| Pathological gambling and major affective disorder: preliminary findings. | Q45296309 | ||
| Gambling and pathological gambling among university students | Q47329708 | ||
| An open naltrexone treatment study in pathological gambling disorder | Q48664762 | ||
| Altered dopamine function in pathological gambling | Q48764278 | ||
| Pathological gambling among high school students | Q48968313 | ||
| Treatment of obsessive-compulsive spectrum disorders with SSRIs | Q50301481 | ||
| Genetic association study between pathological gambling and a functional DNA polymorphism at the D4 receptor gene. | Q50927059 | ||
| Impulse control disorders and attention deficit disorder in pathological gamblers. | Q51021266 | ||
| Biogenic amine-related enzymes and personality variations in normals | Q51022735 | ||
| Pathological gambling and platelet MAO activity: a psychobiological study. | Q51046522 | ||
| Naltrexone as a treatment for repetitive self-injurious behaviour:an open-label trial. | Q51113845 | ||
| Nefazodone and the treatment of nonparaphilic compulsive sexual behavior: a retrospective study. | Q51977165 | ||
| Low platelet monoamine oxidase activity in pathological gambling. | Q52021447 | ||
| Treatment of pathological gambling with carbamazepine. | Q52026507 | ||
| Characteristics of pathological gamblers identified among patients on a psychiatric admissions service. | Q52056214 | ||
| Platelet monoamine oxidase activity in mental disorders: 2. Affective psychoses and suicidal behavior. | Q52105472 | ||
| The prevalence and demographics of pathological gamblers: implications for public health. | Q52273193 | ||
| Naltrexone use in the treatment of anorexia nervosa and bulimia nervosa. | Q52273942 | ||
| The effects of benzodiazepines and serotonergic manipulations on punished responding | Q52301831 | ||
| Obsessive-compulsive and spectrum disorders: overview and quality of life issues. | Q53633002 | ||
| Manic behaviors associated with fluoxetine in three 12- to 18-year-olds with obsessive-compulsive disorder. | Q53950524 | ||
| An open trial of valproate in borderline personality disorder | Q54001001 | ||
| Lithium and lady luck; use of lithium carbonate in compulsive gambling. | Q54298197 | ||
| Personality traits related to monoamine oxidase activity in platelets. | Q54702692 | ||
| Fluvoxamine treatment of body dysmorphic disorder | Q56910658 | ||
| Low platelet monoamine oxidase and sensation seeking in males: an established relationship? | Q60491538 | ||
| Induction of Mania With Serotonin Reuptake Inhibitors | Q60620350 | ||
| Lithium treatment of chronic hair pulling | Q67984993 | ||
| Treatment of pathological gambling with clomipramine | Q68109459 | ||
| Depressed pathological gamblers | Q68338953 | ||
| Fluvoxamine treatment of obsessive-compulsive disorder | Q70368813 | ||
| SSRI-induced mania | Q70915034 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 9-15 | |
| P577 | publication date | 2003-05-01 | |
| P1433 | published in | Current Psychiatry Reports | Q25245507 |
| P1476 | title | Diagnosis and treatment of pathologic gambling | |
| P478 | volume | 5 |
| Q44835101 | A double-blind, placebo-controlled trial of topiramate for pathological gambling |
| Q24810652 | Comorbidity issues in the pharmacological treatment of Pathological Gambling: a critical review. |
| Q35574495 | Pathological gambling: a review of phenomenological models and treatment modalities for an underrecognized psychiatric disorder |
| Q36079333 | Pharmacological treatments of pathological gambling |
| Q36688997 | Pharmacotherapy of pathological gambling: review of new treatment modalities |
| Q43189839 | Social withdrawal and gambling-like profile after lentiviral manipulation of DAT expression in the rat accumbens. |
| Q34418660 | The vulnerable faces of pathological gambling |
| Q39713624 | Topiramate Combined with Cognitive Restructuring for the Treatment of Gambling Disorder: A Two-Center, Randomized, Double-Blind Clinical Trial |
Search more.